Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11973189.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ondansetron orally disintegrating tablet reduces postdischarge nausea and vomiting and improves patient satisfaction with postoperative nausea and vomiting management.
Medical subject headings
- Ambulatory Surgical Procedures
- Antiemetics
- Ondansetron
- Postoperative Nausea and Vomiting